Frontiers in Cardiovascular Medicine | Cardiovascular Pharmacology and Drug Discovery

Confident young woman gesturing while teaching students in class

Submit your research

Start your submission and get more impact for your research by publishing with us.

Active senior woman concentrating while working on laptop

Author guidelines

Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.

Front view portrait of African American man wearing lab coat and raising hand asking question while sitting in audience and listening to lecture on medicine

Editor guidelines

Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.

Smiling colleagues doing research over laptop computer on desk in office

Peer review

Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.

Interior of a library with desks and bookshelves

Publishing fees

Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.

Journal notices

Submission closing: Specialty Chief Editor's Collection on Non-Invasive Cardiovascular Imaging

Submissions close 30 May 2026—last call to join the collection curated by Sebastian Kelle, our Specialty Chief Editor for Cardiovascular Imaging, spanning AI diagnostics, genetics, cardiomyopathies, heart failure, and prevention

Polyvascular Imaging for Cardiovascular Risk Prediction

Submit your work on polyvascular imaging across multiple arterial beds—combining carotid, coronary, femoral, and aortic imaging with AI and biomarkers for enhanced cardiovascular risk prediction. Deadline 15 October 2026.

Reimagining cardiac rehabilitation: lessons from history for a post‑MI future

Explore how cardiac rehabilitation evolved from strict bed rest to modern post‑MI care. Julie Redfern (University of Sydney) and Tom Briffa (University of Western Australia) trace its history and outline how programs must modernize for today’s patients

eBook of the month

Calcification is no longer a bystander. This eBook maps cardiovascular calcification across its clinical phenotypes—from coronary arteries to heart valves—and highlights emerging diagnostic tools and therapeutic targets.

When loop diuretics stop working: how to fight back against diuretic resistance

One in three heart failure patients fails to decongests despite aggressive diuretics. This review unpacks the mechanisms — from tubular adaptation to chloride depletion — and maps a phenotype-tailored playbook for cardiorenal syndrome.

Cardiovascular Pharmacology and Drug Discovery

Submit your research

Author guidelines

Editor guidelines

Peer review

Publishing fees

Journal notices

Submission closing: Specialty Chief Editor's Collection on Non-Invasive Cardiovascular Imaging

Polyvascular Imaging for Cardiovascular Risk Prediction

Reimagining cardiac rehabilitation: lessons from history for a post‑MI future

eBook of the month

When loop diuretics stop working: how to fight back against diuretic resistance

Editors

professor xiaofeng yang, md, phd

adesuyi ajayi md, phd, fbpharmacols, fwacp

wei anhua

tobias eckle

Articles

4,4′-DMAR in-vivo acute cardiotoxicity: differences between (±)cis-4,4′-DMAR and its coadministration with the (±)trans-4,4′-DMAR isomer

Association of achieved LDL-C levels with global coagulability and clinical outcomes in patients with acute coronary syndrome receiving PCSK9 inhibitors: a prospective cohort study

Ticagrelor Plasma Concentration, Metabolite Ratio, and LDH Level as Independent Risk Factors for Ticagrelor-induced Dyspnea in ACS Patients

From Empirical Hemostasis to Precision Reversal: Clinical Challenges, Technological Innovations, and Individualized Strategies in Anticoagulant-Associated Bleeding

Research Topics

Cardiovascular Pharmacotherapy and Kidney Disease: Controversies and Practical Challenges

Mechanosensitive Ion Channels in Cardiovascular Disease: Mechanobiology, Signaling, and Translational Approaches

Compounds from Food and Medicinal Plants as Sources and Inspiration for the Development of Cardiovascular Drugs: Mechanisms, Therapeutic Targets, and Translational Perspectives

Proteases and Protease Inhibitors in Vascular Dysfunction and Therapy